NCT03261544: Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?

NCT03261544
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 16 Years to 75 Years (Child, Adult, Older Adult)
Location of Metastases: Bone
Additional Notes: Patient must be scheduled for proximal femur replacement 
Exclusions: 
https://ClinicalTrials.gov/show/NCT03261544

Comments are closed.

Up ↑